The need for better AD animal models

The need for better AD animal models

Bibliographic Details
Main Authors:	Miguel eMedina, Jesus eAvila
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-10-01
Series:	Frontiers in Pharmacology
Subjects:	Amyloid Dementia Alzheimer neurodegeneration tau Drug Development
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00227/full

Similar Items

The role of extracellular Tau in the spreading of neurofibrillary pathology
by: Miguel eMedina, et al.
Published: (2014-04-01)

Editorial: Untangling the Role of Tau in Physiology and Pathology
by: Miguel Medina, et al.
Published: (2020-05-01)

An Overview on the Clinical Development of Tau-Based Therapeutics
by: Miguel Medina
Published: (2018-04-01)

GSK3 and Alzheimer's disease: facts & fiction …
by: Fred eVanleuven
Published: (2011-08-01)

Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
by: Ricardo F. Allegri, et al.
Published: (2020-01-01)

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
by: Meng-Shan Tan, et al.
Published: (2020-05-01)

Editorial: Tau Pathology in Neurological Disorders
by: Sonia Do Carmo, et al.
Published: (2021-09-01)

CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia
by: Chritica Lodder, et al.
Published: (2021-06-01)

Alzheimer’s disease models and functional genomics - How many needles are there in the haystack?
by: Jurgen eGotz, et al.
Published: (2012-08-01)

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
by: Jurre den Haan, et al.
Published: (2018-12-01)

The role of type 2 diabetes in neurodegeneration
by: Giuseppe Verdile, et al.
Published: (2015-12-01)

Inhibiteurs et modèles moléculaires de fibres amyloïdes ° et tau impliquées dans la maladie d'Alzheimer : conception, synthèse et caractérisation
by: Dufour, Emilie
Published: (2013)

Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice
by: M.K. Schultz, Jr., et al.
Published: (2018-10-01)

Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer’s Disease
by: Valentina Latina, et al.
Published: (2021-03-01)

Transcriptional, Behavioral and Biochemical Profiling in the 3xTg-AD Mouse Model Reveals a Specific Signature of Amyloid Deposition and Functional Decline in Alzheimer’s Disease
by: Wencheng Yin, et al.
Published: (2020-12-01)

Modulation der Tau-Aggregation durch Modifikation der Cystein-Reste im Tau-Protein
by: Karras, Stephanie
Published: (2017)

GSK-3β, a pivotal kinase in Alzheimer disease
by: Maria eLLorens-Martin, et al.
Published: (2014-05-01)

Neurological Mechanisms of Animal-Assisted Intervention in Alzheimer’s Disease: A Hypothetical Review
by: Sujin Kim, et al.
Published: (2021-07-01)

Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
by: M. Catarina Silva, et al.
Published: (2020-11-01)

The Female Impact in the World of Neurodegeneration
by: Celeste Gonzalez Osorio, et al.
Published: (2021-10-01)

New Features about Tau Function and Dysfunction
by: Miguel Medina, et al.
Published: (2016-04-01)

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
by: Meng-Shan Tan, et al.
Published: (2021-01-01)

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia
by: Franc Llorens, et al.
Published: (2017-09-01)

Organotypic brain slice cultures to model neurodegenerative proteinopathies
by: C. L. Croft, et al.
Published: (2019-12-01)

Differences Between Human and Murine Tau at the N-terminal End
by: Félix Hernández, et al.
Published: (2020-01-01)

Impact of sleep disturbances on neurodegeneration: Insight from studies in animal models
by: Jessica E. Owen, et al.
Published: (2020-06-01)

Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer’s and Vascular Dementia Drugs
by: Solomon Habtemariam
Published: (2018-02-01)

Alzheimer’s associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia
by: Thuy-Vi V. Nguyen, et al.
Published: (2018-09-01)

Are AD-typical regions the convergence point of multiple pathologies?
by: Sylvia eVilleneuve, et al.
Published: (2015-03-01)

Amyloid β and tau pathology in brains of aged pinniped species (sea lion, seal, and walrus)
by: Yuta Takaichi, et al.
Published: (2021-01-01)

Imaging Alzheimer's disease pathophysiology with PET
by: Lucas Porcello Schilling, et al.

Canine Cognitive Dysfunction and Alzheimer’s Disease – Two Facets of the Same Disease?
by: Sonja Prpar Mihevc, et al.
Published: (2019-06-01)

Alzheimer's disease and blood-based biomarkers – potential contexts of use
by: Zvěřová M
Published: (2018-07-01)

Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
by: Kevin A. Clayton, et al.
Published: (2017-12-01)

Revisiting the role of acetylcholinesterase in Alzheimer’s disease: cross-talk with P-tau and β-amyloid
by: Maria-Salud eGarcía-Ayllón, et al.
Published: (2011-09-01)

Presenilin/γ-secretase and inflammation
by: Carlos A Saura
Published: (2010-05-01)

Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders
by: Giovanni Bellomo, et al.
Published: (2021-03-01)

Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife
by: Minos Kritikos, et al.
Published: (2020-04-01)

Advances and considerations in AD tau-targeted immunotherapy
by: Alice Bittar, et al.
Published: (2020-02-01)

Improving the Gene Ontology Resource to Facilitate More Informative Analysis and Interpretation of Alzheimer’s Disease Data
by: Barbara Kramarz, et al.
Published: (2018-11-01)